In:
Global Journal of Respiratory Care, Savvy Science Publisher, Vol. 6 ( 2020-06-06), p. 16-21
Abstract:
Background: Malignant Pleural Effusion (MPE) represents an advanced oncological disease. Overall survival ranges between 3 to 12 months depending on different factors. LENT score has emerged as the first validated instrument to predict MPE survival with significant better accuracy. There is no information regarding LENT score in Hispanic population. Therefore, the objective of this study is to analyze the performance of LENT score within a cohort of MPE patients from Mexico. Methods: A retrospective observational study including 32 patients with a confirmed MPE was conducted. Stratification was according to LENT score (low-risk, moderaterisk, high risk). Overall survival was calculated from the date of diagnosis until death and differences between groups were analyzed. Results: The median age was 61years (IQR 47-71) and 47% were women. Based on the stratification of LENT score, 6% was stratified as low-risk, 59% as moderate-risk and 34% as high-risk. Overall median survival time was 54 days (IQR 26-243), and considering the stratification, 227, 53 and 37 days for low, moderate and high-risk groups, respectively. The higher LENT score, the higher the risk of death (HR 2.26, CI 95%, 1.15-4.47, p=0.019). Pleural LDH, ECOG and NLR were the factors that provided greater accuracy to differentiate groups, (p=0.076, p=0.003 y p=0.015, respectively). Conclusion: LENT score showed a good performance to identify patients with the most adverse prognosis and the highest risk of mortality in Hispanic population. Pleural LDH, ECOG and NLR provide the most valuable information in the identification of the cases.
Type of Medium:
Online Resource
ISSN:
2312-5470
DOI:
10.12974/2312-5470.2020.06.02
Language:
Unknown
Publisher:
Savvy Science Publisher
Publication Date:
2020
Bookmarklink